Reuters reported that London Metal Exchange has confirmed a new rule to require warehouse companies with 30,000 tonnes or more of one metal scheduled for delivery to deliver out a minimum 500 tonnes per day of other metals stuck behind that ...
Tags: London Metal Exchange, aluminium, network, metals stuck
CDM Media announced today that Sapiens, a leading global provider of innovative software solutions for the financial services industry, will join the upcoming CIO Insurance Summit, to be held Oct. 14-16, 2012, in Scottsdale, Ariz. ...
Abbott has received US Food and Drug Administration clearance for its new testosterone test, ARCHITECT 2nd generation testosterone assay. The testosterone assay is expected to help physicians to accurately measure the wide range of ...
Tags: FDA, testosterone test, clinical technology
Demand for real-time data, including personal health information, is driving the market for wearable, wireless devices that will grow from 14 million items this year to as many as 171 million in 2016. In four years, the market for ...
Global healthcare firm Abbott's everolimus eluting coronary stent system has been accorded with CE Mark in Europe. The XIENCE Xpedition everolimus eluting coronary stent system, which is used to treat coronary artery disease, provides ...
Tags: Abbott, CE mark, coronary stent system, coronary artery disease
Abbott has obtained the US Food and Drug Administration (FDA) approval for its Omnilink Elite Vascular Balloon-Expandable Stent system, designed as a treatment for atherosclerotic iliac artery lesions with reference vessel diameters of ≥ ...
Tags: Abbott, FDA, approval, Omnilink Elite stent, study, Omnilink Elite
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to STENTYS to conduct a pivotal APPOSITION V clinical study for its Self-Apposing stent. The Self-Apposing technology, which adapts vessels with ...
Simplex Healthcare has entered into collaboration agreement to provide PositiveID's iglucose system, designed for diabetes management. Under the agreement, Simplex will purchase iglucose units and will start trialing the iglucose ...
Tags: Diabetes Management System, clinical application, Simplex
The US Food and Drug Administration (FDA) has approved Abbott's Healon EndoCoat ophthalmic viscosurgical device (OVD). The Healon EndoCoat OVD is a clear, viscous, protective gel intended for use as a surgical aid in cataract ...
Tags: FDA, clinical product, ophthalmic viscosurgical device
The premier trade event of the UAE’s aluminium industry, the 16th Arab International Aluminium Conference (ARABAL 2012) was held at the Grand Hyatt Doha, Qatar from 20 to 22 November. The conference, taking place under the patronage ...
Tags: UAE's aluminium industry, ARABAL, aluminium conference
In response to Federal Opposition Leader Tony Abbott continuing his truck drive from Brisbane to Terrigal, Australasian Railway Association (ARA) CEO Bryan Nye has invited Mr Abbott to travel by rail instead. Daniel Hurst / ...
Tags: truck drive, additional carbon dioxide emissions, regional centres
BG Medicine has registered a 510(k) premarket notification with the US Food and Drug Administration (FDA) for approval of its Architect Galectin-3 assay. The Architect Galectin-3 assay, which is designed for use with Abbott's automated ...
Tags: BG Medicine, premarket notification, FDA, Architect Galectin-3 assay
IntelligentMDx has received CE mark approval for its automated molecular HSV-1/2 test, designed for the Abbott m2000 system. The HSV-1/2 for Abbott m2000 assay detects Herpes Simplex Virus (HSV) viral DNA and differentiates HSV-1 and ...
Tags: IntelligentMDx, HSV-1/2 test, Abbott m2000 system, HSV
SPI subsidiary Sucampo Pharmaceuticals has received approval from the Ministry of Health, Labor and Welfare in Japan for Amitiza (lubiprostone), a prescription drug for the treatment of chronic constipation, excluding constipation caused by ...
Tags: amitiza, lubiprostone, treatment of chronic constipation, prostone
Cardiovascular diagnostics developer BG Medicine has filed a 510(k) Premarket Notification with the US Food and Drug Administration (FDA) for regulatory clearance for the ARCHITECT Galectin-3 assay. Used with Abbott's fully automated ...